These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6351950)

  • 1. Progesterone receptors and human breast cancer.
    Clark GM; McGuire WL
    Breast Cancer Res Treat; 1983; 3(2):157-63. PubMed ID: 6351950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of progesterone receptors in human breast cancer.
    McGuire WL; Clark GM
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):2-6. PubMed ID: 6669985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative importance of estrogen and progesterone receptor assays as prognostic indicators in primary breast cancer: a short-term study.
    Brocklehurst D; Wilde CE; Finbow JA; Brett R; Champion AE; Dewhurst DG
    Clin Chem; 1989 Feb; 35(2):238-40. PubMed ID: 2914367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptors in the management of human breast cancer.
    Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
    Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptors as a prognostic factor in Stage II breast cancer.
    Clark GM; McGuire WL; Hubay CA; Pearson OH; Marshall JS
    N Engl J Med; 1983 Dec; 309(22):1343-7. PubMed ID: 6633596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of progesterone receptors in breast cancer.
    McGuire WL; Clark GM
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):12-6. PubMed ID: 3975645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of estrogen and progesterone receptors in the treatment of breast cancer.
    Osborne CK; Yochmowitz MG; Knight WA; McGuire WL
    Cancer; 1980 Dec; 46(12 Suppl):2884-8. PubMed ID: 7448733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
    Kurozumi S; Matsumoto H; Inoue K; Tozuka K; Hayashi Y; Kurosumi M; Oyama T; Fujii T; Horiguchi J; Kuwano H
    PLoS One; 2018; 13(8):e0201846. PubMed ID: 30080878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of progesterone receptor assays in the management of advanced breast cancer.
    Degenshein GA; Bloom N; Tobin E
    Cancer; 1980 Dec; 46(12 Suppl):2789-93. PubMed ID: 7448722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study.
    Kai K; Nishimura R; Arima N; Miyayama H; Iwase H
    Int J Clin Oncol; 2006 Dec; 11(6):426-33. PubMed ID: 17180510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution.
    Tsuji W; Teramukai S; Ueno M; Toi M; Inamoto T
    Breast Cancer; 2014 Jan; 21(1):86-95. PubMed ID: 22477265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of measuring hormone receptor levels of regional metastatic carcinoma of the breast.
    Butler JA; Trezona T; Vargas H; State D
    Arch Surg; 1989 Oct; 124(10):1131-4; discussion 1134-5. PubMed ID: 2802974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of estrogen and progesterone receptors in stage II breast cancer.
    Rydén S; Fernö M; Borg A; Hafström L; Möller T; Norgren A
    J Surg Oncol; 1988 Apr; 37(4):221-6. PubMed ID: 3283457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of presence of progesterone receptors to prognosis in early breast cancer.
    Pichon MF; Pallud C; Brunet M; Milgrom E
    Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis.
    Molino A; Turazza M; Bonetti A; Biondani P; Griso C; Adami L; Corgnati A; Nortilli R; Pollini GP; Modena S
    Oncology; 1992; 49(2):82-8. PubMed ID: 1574256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.